Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
6
×
life sciences
national blog main
san diego blog main
6
×
boston blog main
clinical trials
san diego top stories
san francisco blog main
biotech
boston top stories
new york blog main
san francisco top stories
indiana blog main
national top stories
new york top stories
raleigh-durham blog main
seattle blog main
alnylam pharmaceuticals
boston
boston university
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana top stories
national
raleigh-durham top stories
regeneron pharmaceuticals
rna interference
seattle top stories
software
startups
texas blog main
texas top stories
vc
venture capital
wisconsin blog main
wisconsin top stories
3d imaging
What
patients
6
×
fda
drug
developers
medicine
therapy
time
add
ago
alnylam
approve
aren’t
awaits
beta
bio
biological
bionics
blood
called
cancer
carbidopa
closed
combination
control
crossed
daily
daunting
decades
decision
developing
device
diabetes
discovered
disease
driven
drugs
eisai
experience
fingers
firms
Language
unset
Current search:
fda
×
patients
×
" san diego blog main "
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets